Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,264,625 papers from all fields of science
Search
Sign In
Create Free Account
Glycopyrrolate 0.0156 MG Inhalant Powder [Seebri]
Known as:
Seebri 0.0156 MG Inhalant Powder
, GLYCOPYRROLATE 15.6 ug RESPIRATORY (INHALATION) CAPSULE [SEEBRI NEOHALER]
, seebri neohaler 15.6 MCG Inhalant Powder Capsule
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Glycopyrrolate
Inhalant Powder
Lactose Monohydrate
Magnesium stearate
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Seebri Neohaler and Utibron Neohaler for COPD.
The Medical letter on drugs and therapeutics
2016
Corpus ID: 10833092
2014
2014
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
M. Miravitlles
,
K. Beeh
,
P. Altman
2014
Corpus ID: 30540760
The clinical development of the long-acting muscarinic antagonist bronchodilator glycopyrronium (Seebri® Breezhaler® inhalation…
Expand
Review
2013
Review
2013
Glycopyrronium (Seebri Breezhaler): once‐daily LAMA for COPD
S. Chaplin
,
A. Turner
2013
Corpus ID: 70465878
Glycopyrronium is a new LAMA for maintenance treatment of COPD. In our New products review, Steve Chaplin presents the clinical…
Expand
Review
2013
Review
2013
▼Glycopyrronium for COPD
Drug and therapeutics bulletin
2013
Corpus ID: 206924477
▼Glycopyrronium powder for inhalation (Seebri Breezhaler—Novartis) is a long-acting muscarinic receptor antagonist (LAMA…
Expand
2012
2012
Seebri Breezhaler, INN-glycopyrronium
Seebri Breezhaler
2012
Corpus ID: 3680539
1984
1984
“FDA-approved” indications
D. A. Anderson
1984
Corpus ID: 86434648
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE